Where is Allena headquartered?

Allena is located in Newton, MA.

Who invested in Allena?

Allena has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Allena?

Allena closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

allenapharma.com

Allena

Allena is a Massachusetts-based biopharmaceutical company that develops and commercializes oral enzyme therapeutics for the treatment of chronic kidney diseases.

Business Model:

Revenue: $4.4M

Employees: 11-50

Geographic Data

Address: One Newton Executive Park

City: Newton

State: MA

Zip: 02462

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$3B

Raised Total:

$150M

Social

Facebook

Twitter

Crunchbase

Metrics

3,638,281Website Global Rank

3,634Website Monthly Traffic

Twitter Followers

Description

Allena is a Massachusetts-based biopharmaceutical company that develops and commercializes oral enzyme therapeutics for the treatment of chronic kidney diseases.

Contact Phone:
+16174674577

Contact Email:

IPO Details

Allena went public on 11/2/2017 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/2/2017

IPO Valuation:
$288M

Ticker Symbol:
ALNA

IPO Price:
$14/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
10/2017	IPO		-
11/2011	Series A	3	$15M	Bessemer Venture Partners Frazier Healthcare Partners Third Rock Ventures Bessemer Venture Partners Frazier Healthcare Partners Third Rock Ventures
12/2014	Series B		$0	Bessemer Venture Partners Inbio Ventures Pharmstandard HBM Partners Third Rock Ventures Frazier Healthcare Partners Bessemer Venture Partners Inbio Ventures Pharmstandard HBM Partners Third Rock Ventures Frazier Healthcare Partners
12/2015	Series C		$0	Partner Fund Management Wellington Management Fidelity Management and Research Company Inbio Ventures Frazier Healthcare Partners Partner Fund Management Partner Fund Management Wellington Management Fidelity Management and Research Company Inbio Ventures Frazier Healthcare Partners Partner Fund Management
11/2017	Post-IPO Equity	1	-	Bessemer Venture Partners Bessemer Venture Partners
7/2021	Post-IPO Equity		$28M
9/2020	Post-IPO Debt	1	$25M	Pontifax Pontifax Pontifax Pontifax
5/2022	Post-IPO Equity		$2.8B
5/2022	Post-IPO Equity		$4.1M
10/2017	IPO		-
12/2015	Series C	5	$53M	Partner Fund Management Wellington Management Frazier Healthcare HBM Partners AG Pharmstandard International, S.A. Partner Fund Management Wellington Management Fidelity Management and Research Company Inbio Ventures Frazier Healthcare Partners Partner Fund Management
11/2017	Post-IPO Equity	1	-	Bessemer Venture Partners Bessemer Venture Partners
12/2014	Series B	6	$25M	Bessemer Venture Partners Inbio Ventures Pharmstandard HBM Partners Bessemer Venture Partners Inbio Ventures Pharmstandard HBM Partners

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details